Document is current
Any future updates will be listed below
-
Authors
Matulis, Shannon M.
Gupta, Vikas A.
Neri, Paola
Bahlis, Nizar J.
Maciag, Paulo
Leverson, Joel D.
Heffner, Leonard T.
Lonial, Sagar
Nooka, Ajay K.
Kaufman, Jonathan L.
Boise, Lawrence H.
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA138292, R01 CA192844)
-
License Information
Text and Data Mining valid from 2019-01-24
-
More Information
Article History
Received: 6 August 2018
Revised: 19 October 2018
Accepted: 29 October 2018
First Online: 24 January 2019
Compliance with ethical standards
:
: NJB, funding and honorarium from Celgene and Janssen; PM and JDL, employment, Abbvie; LTH, research funding, Abbvie; SL, consultancy, Takeda, Celgene, Novartis, Abbvie, Amgen, Janssen, Bristol-Myers Squibb; AKN, advisory board or consultancy, Amgen, Adaptive Technologies, Janssen, Celgene, Spectrum Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, Takeda; JLK, Consultancy, Abbvie, Janssen, Bristol-Myers Squibb, Takeda, Data Monitoring Committee, Karyopharm, Pharmacyclics; LHB, consultancy, Abbvie, honorarium, AstraZeneca. The other authors declare that they have no conflict of interest.
